Skip to main content
Xellia

We are Xellia

Built for continuity. Focused on what matters.

In anti-infectives, what matters is not just what you make — but whether it’s there when it’s needed.

As supply chains become more complex and critical APIs disappear from Western production, continuity can no longer be taken for granted. It has to be built, maintained, and protected over time.

That is where we focus.

What we stand for

Our mission is to deliver critical medicine, on time, every time - because patients can't wait

26_0226_Xellia_Production_DSF7360.jpg

Xellia is a global leader in fermentation-based anti-infectives, delivering both APIs and finished dosage forms used in the treatment of severe and often life-threatening infections.

We are one of the last Western manufacturers of several essential anti-infective APIs, with EU-based production and a long-standing track record of uninterrupted supply.

Our position is not incidental. It is the result of sustained focus, deep expertise, and a commitment to staying in a category others have left. We exist to ensure that critical medicines remain available — reliably, consistently, and without interruption.

This means taking responsibility beyond production: staying ahead of evolving standards, investing in long-term capability, and working closely with our partners to anticipate and solve challenges before they impact supply.

Because in this category, delays are not just operational — they are critical.

Let's talk about partnership
What we stand for

Our mission is to deliver critical medicine, on time, every time - because patients can't wait

Xellia is a global leader in fermentation-based anti-infectives, delivering both APIs and finished dosage forms used in the treatment of severe and often life-threatening infections.

We are one of the last Western manufacturers of several essential anti-infective APIs, with EU-based production and a long-standing track record of uninterrupted supply.

Our position is not incidental. It is the result of sustained focus, deep expertise, and a commitment to staying in a category others have left. We exist to ensure that critical medicines remain available — reliably, consistently, and without interruption.

This means taking responsibility beyond production: staying ahead of evolving standards, investing in long-term capability, and working closely with our partners to anticipate and solve challenges before they impact supply.

Because in this category, delays are not just operational — they are critical.

Let's talk about partnership

Xellia's leadership

Meet our experienced executive team, leading Xellia into the future.

Michael Kocher

26_0225_Xellia_Excutives_Michael_Contact.jpg

Chief Executive Officer

Michael joined Xellia as Chief Executive Officer in October 2023, bringing extensive global experience from the anti-infective industry.

Michael Kocher

Gaël Bernard

26_0225_Xellia_Excutives_Gael_Contact.jpg

Chief Commercial Officer

Gaël Bernard has spent nearly three decades in the pharmaceutical industry, building and leading businesses across global markets.

Gaël Bernard

Florian Falch

26_0225_Xellia_Excutives_Florian_Contact.jpg

Chief People & Culture Officer

Florian Falch joined Xellia in September 2023 and brings extensive experience in strategy, transformation, and M&A from the global pharmaceutical industry.

Florian Falch

Vicente Oller

26_0225_Xellia_Excutives_Vincente_Contact.jpg

Chief Financial Officer

Vicente joined Xellia Pharmaceuticals in September 2024 prior to that, he was the CFO of the Global B2B business at Sandoz and served as the Country CFO for Sandoz Austria.

Vicente Oller

Alexander Sproedt

26_0225_Xellia_Excutives_Alex_Contact.jpg

Chief Operations Officer

Alex joined Xellia in November 2024 and serves as Chief Operations Officer, bringing more than a decade of experience across the Life Sciences industry.

Alexander Sproedt
Our heritage

120+ years inanti-infectives

More than a century of focus, development, and production

From our origins in early pharmaceutical research to our position today as a global manufacturer of critical anti-infectives, Xellia’s history is defined by continuity. Through changing technologies, ownership structures, and market conditions, one thing has remained constant: a long-term commitment to developing and manufacturing medicines the world depends on.

Our values

Everything we do is shaped by our values

26_0227_Xellia_Production_DSF9500.jpg

At Xellia, our values are not statements on a page. They are the way we work, make decisions, and deliver for our customers and each other. They guide our behaviour — every day.

Make it matter
Our purpose is to save lives – make every day, every task matter

We focus on what truly creates impact. That means prioritizing what matters most, making conscious choices, and ensuring our work contributes to impact.

Speak truth
We tell it as it is — because trust matters

We build trust through openness and honesty. We ask questions, challenge assumptions, and give and receive feedback — even when it's not easy.

Own it
Our expectation is clear - take ownership end-to-end

We take responsibility when something needs attention. We act, follow through, and ensure things move forward — beyond roles and handovers.

Play to win
We show up to lead – as one global team

We are ambitious and performance-driven. We work collaboratively, learn continuously, and strive to deliver strong results — today and for the future.

Want to join our team?
Our values

Everything we do is shaped by our values

At Xellia, our values are not statements on a page. They are the way we work, make decisions, and deliver for our customers and each other. They guide our behaviour — every day.

Make it matter
Our purpose is to save lives – make every day, every task matter

We focus on what truly creates impact. That means prioritizing what matters most, making conscious choices, and ensuring our work contributes to impact.

Speak truth
We tell it as it is — because trust matters

We build trust through openness and honesty. We ask questions, challenge assumptions, and give and receive feedback — even when it's not easy.

Own it
Our expectation is clear - take ownership end-to-end

We take responsibility when something needs attention. We act, follow through, and ensure things move forward — beyond roles and handovers.

Play to win
We show up to lead – as one global team

We are ambitious and performance-driven. We work collaboratively, learn continuously, and strive to deliver strong results — today and for the future.

Want to join our team?
26_0227_Xellia_Production_DSF9500.jpg
Join our team

Make a difference to people's lives

26_0226_Xellia_Production_DSF5518.jpg

Take responsibility. Build expertise. Help keep critical medicines moving.

At Xellia, there’s no distance between your work and its impact. You’re trusted to take responsibility, develop your expertise, and contribute from day one.

We work in a category where what we do matters — and where collaboration, curiosity, and accountability shape how we move forward.

Be one of our people
Join our team

Make a difference to people's lives

Take responsibility. Build expertise. Help keep critical medicines moving.

At Xellia, there’s no distance between your work and its impact. You’re trusted to take responsibility, develop your expertise, and contribute from day one.

We work in a category where what we do matters — and where collaboration, curiosity, and accountability shape how we move forward.

Be one of our people
26_0226_Xellia_Production_DSF7610.jpg

Novo Holdings A/S

Novo Holdings A/S acquired Xellia Pharmaceuticals on May 21st 2013. Novo Holdings' expertise in the life sciences sector and long-term ownership model will help Xellia accelerate investments in product development and innovation.

Let's talk!

We are built on partnerships and relationships.
Reach out today, and let's start the conversation.

Optional